543500 EVOQ

Evoq Remedies Share Price

₹7.85 -0.17 (-2.12%)

22 Dec, 2024 11:52

SIP TrendupStart SIP in EVOQ

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 7.39%
  • Over 3 Month -11.3%
  • Over 6 Month -17.28%
  • Over 1 Year -32.33%
SIP Lightning

Smart Investing Starts Here Start SIP with Evoq Remedies for Steady Growth!

Invest Now

Evoq Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Evoq Remedies Financials

Evoq Remedies Technicals

EMA & SMA

Current Price
₹7.85
-0.17 (-2.12%)
pointer
  • stock-down_img
  • Bullish Moving Average 2
  • stock-up_img
  • Bearish Moving Average 14
  • 20 Day
  • ₹7.89
  • 50 Day
  • ₹8.03
  • 100 Day
  • ₹8.53
  • 200 Day
  • ₹9.58

Resistance and Support

7.92 Pivot Speed
  • R3 8.17
  • R2 8.10
  • R1 7.99
  • S1 7.81
  • S2 7.74
  • S3 7.63

What's your outlook on Evoq Remedies?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Evoq Remedies has an operating revenue of Rs. 51.25 Cr. on a trailing 12-month basis. An annual revenue de-growth of -76% needs improvement, Pre-tax margin of 15% is great, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 56 indicates it belongs to a fair industry group of Medical-Ethical Drugs and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Evoq Remedies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-05-27 Audited Results
2024-01-22 Preferential issue of shares
2023-11-10 Half Yearly Results (Revised)
2023-05-25 Audited Results
2022-11-07 Half Yearly Results & Rights issue

Evoq Remedies F&O

Evoq Remedies Shareholding Pattern

11.21%
85.75%
3.04%

About Evoq Remedies

  • NSE Symbol
  • EVOQ
  • BSE Symbol
  • 543500
  • Managing Director
  • Mr. Bhumishth Patel
  • ISIN
  • INE0JVD01011

Similar Stocks to Evoq Remedies

Evoq Remedies FAQs

Evoq Remedies share price is ₹7 As on 22 December, 2024 | 11:38

The Market Cap of Evoq Remedies is ₹19.5 Cr As on 22 December, 2024 | 11:38

The P/E ratio of Evoq Remedies is As on 22 December, 2024 | 11:38

The PB ratio of Evoq Remedies is 0.8 As on 22 December, 2024 | 11:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23